Clinical trial

Clinical Validation Study for EDIT-B Test: an Aid for Differential Diagnosis of Bipolar Disorder, Based on RNA Editing Blood Biomarkers

NCT05603819

Study summary

ClinicalTrials.gov

Clinical Validation Study for EDIT-B Test: an Aid for Differential Diagnosis of Bipolar Disorder, Based on RNA Editing Blood Biomarkers

Design: OBSERVATIONAL · Status: COMPLETED · Phase: Not specified

Loading study purpose, treatment groups and outcomes…

View the complete registry record, eligibility and contacts at ClinicalTrials.gov

Drugs and interventions used in this trial

1 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

DEVICE · Unmapped registry intervention EDIT-B Find medicine records · Find other trials using this name

StatusCOMPLETED

Study typeOBSERVATIONAL

Start date2022-06-29

PhaseN/A

Conditions

Bipolar Disorderverified · MONDO: bipolar disorder

Major Depressive Disorderverified · MONDO: major depressive disorder

Interventions

EDIT-BDEVICE

Sponsors & collaborators

Alcediaglead sponsor

Hospital Clinic of Barcelonacollaborator

Fundacion Clinic per a la Recerca Biomédicacollaborator

Region Capital Denmarkcollaborator

GHU Paris Psychiatry & Neurosciencescollaborator

Parc Sanitari Sant Joan de Déucollaborator

Fundació Sant Joan de Déucollaborator

Synlab Italiecollaborator

Mapped research locations

BarcelonaSpain1 ParisFrance1 CopenhagenDenmark1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT05603819 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.